News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,703 Results
Type
Article (23132)
Company Profile (30)
Press Release (359537)
Multimedia
Podcasts (134)
Webinars (16)
Section
Business (118803)
Career Advice (1422)
Deals (17299)
Drug Delivery (76)
Drug Development (42042)
Employer Resources (96)
FDA (8764)
Job Trends (8384)
News (189484)
Policy (16995)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1467)
Academic (1)
Accelerated approval (30)
ADA (30)
Adcomms (17)
Allergies (116)
Alliances (33107)
ALS (142)
Alzheimer's disease (1074)
Antibody-drug conjugate (ADC) (319)
Approvals (9144)
Artificial intelligence (492)
ASCO (214)
Autoimmune disease (228)
Automation (40)
Bankruptcy (157)
Best Places to Work (6965)
BIOSECURE Act (6)
Biosimilars (142)
Biotechnology (25)
Bladder cancer (139)
Brain cancer (39)
Breast cancer (511)
Cancer (4074)
Cardiovascular disease (332)
Career advice (1235)
Career pathing (35)
CAR-T (186)
CDC (31)
Celiac Disease (1)
Cell therapy (604)
Cervical cancer (34)
Clinical research (37447)
Collaboration (1625)
Company closure (2)
Compensation (374)
Complete response letters (38)
COVID-19 (1514)
CRISPR (75)
C-suite (632)
Cystic fibrosis (86)
Data (5854)
Decentralized trials (3)
Denatured (47)
Depression (103)
Dermatology (62)
Diabetes (441)
Diagnostics (3767)
Digital health (38)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (222)
Drug pricing (105)
Drug shortages (21)
Duchenne muscular dystrophy (192)
Earnings (59499)
Editorial (51)
Employer branding (12)
Employer resources (84)
Events (59014)
Executive appointments (612)
FDA (11290)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (12)
Frontotemporal dementia (28)
Funding (1019)
Gene editing (154)
Generative AI (49)
Gene therapy (504)
GLP-1 (668)
Government (2409)
Grass and pollen (6)
Guidances (346)
Healthcare (10262)
Hematology (124)
HIV (63)
Huntington's disease (38)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (77)
Immunology and inflammation (167)
Immuno-oncology (71)
Indications (150)
Infectious disease (1719)
Inflammatory bowel disease (145)
Inflation Reduction Act (12)
Influenza (78)
Intellectual property (186)
Interviews (268)
IPO (8360)
IRA (30)
Job creations (1718)
Job search strategy (991)
JPM (44)
Kidney cancer (12)
Labor market (64)
Layoffs (261)
Leadership (35)
Legal (4376)
Liver cancer (53)
Longevity (20)
Lung cancer (550)
Lymphoma (320)
Machine learning (35)
Management (33)
Manufacturing (674)
MASH (154)
Medical device (6829)
Medtech (6913)
Mergers & acquisitions (9761)
Metabolic disorders (1065)
mRNA (137)
Multiple sclerosis (138)
NASH (9)
Neurodegenerative disease (268)
Neuropsychiatric disorders (61)
Neuroscience (2055)
NextGen: Class of 2026 (3374)
Non-profit (2704)
Now hiring (12)
Obesity (456)
Opinion (211)
Ovarian cancer (139)
Pain (153)
Pancreatic cancer (201)
Parkinson's disease (234)
Partnered (21)
Patents (353)
Patient recruitment (370)
Peanut (32)
People (28462)
Pharmaceutical (9)
Pharmacy benefit managers (18)
Phase 1 (11247)
Phase 2 (15948)
Phase 3 (13354)
Pipeline (6906)
Policy (182)
Postmarket research (1633)
Preclinical (4952)
Press Release (32)
Prostate cancer (276)
Psychedelics (33)
Radiopharmaceuticals (211)
Rare diseases (722)
Real estate (2573)
Recruiting (37)
Regulatory (13541)
Reports (24)
Research institute (1380)
Resumes & cover letters (218)
Rett syndrome (27)
RNA editing (14)
RSV (53)
Schizophrenia (118)
Series A (181)
Series B (109)
Service/supplier (3)
Sickle cell disease (85)
Special edition (14)
Spinal muscular atrophy (84)
Sponsored (31)
Startups (1536)
State (1)
Stomach cancer (11)
Supply chain (67)
Tariffs (39)
The Weekly (86)
Vaccines (670)
Venture capital (67)
Weight loss (281)
Women's health (74)
Worklife (15)
Date
Today (84)
Last 7 days (401)
Last 30 days (1994)
Last 365 days (19289)
2026 (9340)
2025 (18938)
2024 (20143)
2023 (22147)
2022 (28074)
2021 (29862)
2020 (29096)
2019 (24992)
2018 (18477)
2017 (17408)
2016 (16963)
2015 (19313)
2014 (16242)
2013 (14217)
2012 (14034)
2011 (13460)
2010 (12673)
Location
Africa (548)
Alabama (66)
Alaska (4)
Arizona (159)
Arkansas (8)
Asia (22256)
Australia (3668)
California (8163)
Canada (2343)
China (870)
Colorado (382)
Connecticut (428)
Delaware (262)
Europe (52608)
Florida (1330)
Georgia (280)
Hawaii (1)
Idaho (25)
Illinois (649)
India (67)
Indiana (451)
Iowa (10)
Japan (378)
Kansas (80)
Kentucky (22)
Louisiana (26)
Maine (35)
Maryland (994)
Massachusetts (5927)
Michigan (241)
Minnesota (359)
Mississippi (2)
Missouri (68)
Montana (11)
Nebraska (9)
Nevada (90)
New Hampshire (37)
New Jersey (2572)
New Mexico (15)
New York (2277)
North Carolina (1074)
North Dakota (6)
Northern California (4043)
Ohio (215)
Oklahoma (16)
Oregon (19)
Pennsylvania (1752)
Puerto Rico (10)
Rhode Island (26)
South America (751)
South Carolina (36)
Southern California (3371)
Tennessee (151)
Texas (1320)
United States (29643)
Utah (269)
Vermont (1)
Virginia (188)
Washington D.C. (52)
Washington State (662)
West Virginia (2)
Wisconsin (70)
Wyoming (2)
382,703 Results for "kleiner perkins caufield and byers".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee
April 21, 2026
·
7 min read
Press Releases
Altasciences Announces Chris Perkin Appointed Executive Chairman; Marie-Hélène Raigneau Appointed Chief Executive Officer
February 12, 2026
·
5 min read
BioMidwest
Kleiner Device Labs Presents e-Poster at Southern Neurosurgical Society Meeting: “Rethinking Posterior MIS Fusion - Enabling Risk Reduction in Posterior Spinal Surgery”
Kleiner Device Labs announced that an e-Poster has been accepted for the Southern Neurosurgical Society’s 2024 annual conference beginning on March 7 in Orlando.
February 29, 2024
·
2 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Kleiner Device Labs Awarded Patent for KG®2 Surge® flow-thru interbody system
Kleiner Device Labs today announced that it was recently awarded a U.S. patent for its new KG®2 Surge® flow-thru interbody system.
October 9, 2023
·
2 min read
Biotech Bay
Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek
June 3, 2021
·
3 min read
BioMidwest
Dr. Jeff Kleiner Discusses Innovations in Spinal Fusion Bone Grafting at Seattle Science Foundation MIS Spine Symposium
Jeff Kleiner, M.D., was a featured speaker at the Seattle Science Foundation’s July 21 spine symposium: New and Emerging Techniques & Technologies in MIS Surgery.
August 8, 2023
·
1 min read
Kleiner Device Labs Completes First 50 Surgical Cases With KG2 Surge Flow-Thru Interbody System
Kleiner Device Labs today announced that its new KG®2 Surge®flow-thru interbody system was recently used in its 50th surgical case.
August 17, 2023
·
2 min read
Business
Ziopharm Oncology Names James Huang to Board of Directors
– Industry veteran entrepreneur with 20+ years’ experience founding and financing successful, innovative biotech companies including GenScript and Legend Biotech – – Managing Partner at Kleiner Perkins Caufield & Byers China; Founder of Panacea Venture, funding source for Ziopharm’s joint venture Eden BioCell –
July 22, 2020
·
6 min read
Kleiner Device Labs Completes First Surgery With KG2 Surge Flow-Thru Interbody System
Kleiner Device Labs today announced that its new KG™2 Surge™ flow-thru interbody system was used in its first surgical procedure.
August 1, 2022
·
3 min read
1 of 38,271
Next
